2nd Quarter - Report

INTERNATIONAL COLLABORATION ON COSMETICS SAFETY for INTERNATIONAL COLLABORATION ON COSMETICS SAFETY

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

General health and safety issues related to sunscreen active ingredients; adoption of non-animal testing methodologies; implementation of the SAFE Sunscreen Standards Act (H.R. 3686) and the Continuing Appropriations and Extensions Act, 2026 (P.L. 119-37).

LobbyistCovered position, as disclosed
DAVID ALLEN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 3686 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.